BackTrillium Therapeutics Overview

Trillium Therapeutics Net Income

Profitability analysis for TRIL.

Quarterly Net Income

-$19.32M
61.77% YoY

As of Sep 2021

Annual Net Income (TTM)

$65.08M
130.32% YoY

Trailing 12 months ending Sep 2021

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...